Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

GnRH antagonist elagolix sodium improves endometriosis symptoms in Petal study

Oct. 20, 2009

K-101 topical solution eradicates infection in adults with distal subungual onychomycosis

Oct. 20, 2009

BIBF-1120 maintenance therapy may delay disease progression in ovarian cancer

Oct. 20, 2009

Phase II data for p53-SLP vaccine in ovarian cancer reported

Oct. 20, 2009

Inhaled AIR-645 well tolerated in phase I study

Oct. 20, 2009

Cenomed BioSciences presents anti-emetic candidate devoid of anxiogenic effects

Oct. 19, 2009

A-940894 shows potent in vivo/in vitro anti-inflammatory activity

Oct. 19, 2009

Anti-Fas IgM monoclonal antibody ARG-098 decreases rheumatoid arthritis activity

Oct. 19, 2009

Selective glucocorticoid receptor modulator has less effect on bone biomarkers

Oct. 19, 2009

Medarex releases full phase II results with MDX-100 in rheumatoid arthritis

Oct. 19, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...